Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BLMN | BJRI |
|---|---|---|
| Price | $8.17 | $59.32 |
| Change today | ▼ 1.98% | ▼ 3.28% |
| Market cap | $699.52M | $1.26B |
| Return, 3 months | +1.4% | -1.5% |
| Return, year to date | +32.4% | +50.6% |
| Return, 1 year | +8.4% | +90.7% |
| P/E (TTM) | 25.5 | 31.4 |
| P/B | 1.6 | 3.2 |
| P/E percentile vs own 5y | 73rd | 55th |
| Dividend yield | 1.84% | – |
| Revenue growth (YoY, latest qtr) | +1.3% | +6.4% |
| Net profit growth (YoY) | +22.2% | -15.4% |
| Gross margin | 13.4% | 15.5% |
| Operating margin | 3.2% | 3.0% |
| Net margin | 0.7% | 2.9% |
| Return on equity | 6.7% | 10.4% |
| Analyst target vs. price | +43.9% | +29.8% |
| Analyst buy share | 0% | 60% |
| RSI (14) | 42 | 44 |
| 30-day volatility | 58.0% | 36.9% |
| Max drawdown, 1 year | -34.8% | -26.5% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
